Metabolomics approaches in experimental allergic encephalomyelitis

Area of Science:

• Neuroscience
• Immunology
• Biochemistry

Background:

• Experimental allergic encephalomyelitis (EAE) is an autoimmune disease model.
• EAE is induced by myelin basic protein (MBP) and causes spinal cord inflammation and paraplegia.
• Understanding the metabolic changes during EAE is crucial for developing treatments.

Purpose of the Study:

• To identify metabolic biomarkers of inflammation in EAE.
• To pinpoint the location of central nervous system (CNS) inflammation during acute EAE.
• To utilize metabolomics for disease insight.

Main Methods:

• Induction of EAE in a preclinical model.
• Metabolomic analysis of CNS samples.
• Correlation of metabolic profiles with clinical signs.

Main Results:

• EAE samples showed elevated lactate, ascorbate, glucose, and amino acids compared to controls.
• A significant decrease in N-acetyl-aspartate (NAA) was observed in EAE samples.
• Reduced NAA levels were specifically noted in the lumbar spinal cord, correlating with clinical symptoms.

Conclusions:

• Metabolomic profiling can identify biomarkers for EAE inflammation.
• N-acetyl-aspartate (NAA) decrease is a potential biomarker for CNS inflammation in EAE.
• Lumbar spinal cord inflammation is a key feature associated with clinical signs in EAE.